The Norton Lab will collaborate with Biotech company Q-Vant Biosciences to develop a new oral vaccine platform for prevention of multiple infectious diseases. The platform…
Dr. Elizabeth Norton and Dr. Jay Kolls were awarded an NIH contract to bring a nasal spray pneumonia vaccine to Phase One clinical trial. This…
New NIH R56 grant on ETEC vaccination with dmLT Adjuvant. The objective of this proposal is to test samples from an ETEC vaccine clinical trial and seek…
With the advent of the COVID-19 pandemic, the Norton lab joined forces with other Tulane Investigators including Dr. James Robinson, Dr. John Schieffelin, Dr. Kevin…
In May, members of Norton Lab flew to Seattle for the American Association of Immunologists (AAI) 2016 Annual Meeting at the Washington State Convention Center. In…
This was a busy fall for Norton Lab! We received an NIH RO1 grant for testing the efficacy of new generation proteins, LTA and LTA1, as…
According to the CDC, everyone 6 months and older should get the annual flu vaccination, with rare exception (1). Influenza is a serious disease that can lead…
On October 28th, WGNO swung by Norton Lab to talk to interview Dr. Norton about her $1.6 million NIH grant to develop new adjuvants for…
Do you want to make an impact in your community? Do you want to be a part of defining future healthcare for others? Do you…